反応 #199

ord-8fcffc24262340ad8745959198669390

反応方程式

Clc1ccc(OCc2ccccc2)cn1
Clc1ccc(OCc2ccccc2)c
CC(C)(C)OC(=O)N1CCNCC1
CC(C)(C)OC(=O)N1CCNC
CC(C)(C)OC(=O)N1CCN(c2ccc(OCc3ccccc3)cn2)CC1
CC(C)(C)OC(=O)N1CCN(
収率 68.8%

溶媒

反応条件

温度
80°CELSIUS

実験手順

BIS(DIBENZYLIDENEACETONE)PALLADIUM (0.055 g, 0.10 mmol) was added to tert- butyl piperazine-1-carboxylate (1.952 g, 10.48 mmol), 5-(benzyloxy)-2-chloropyridine (2.093 g, 9.53 mmol), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.059 g, 0.10 mmol) and sodium 2-methylpropan-2-olate (1.282 g, 13.34 mmol) in toluene (30 mL) at 20ºC under nitrogen. The resulting solution was stirred at 80 °C for 16 hours then cooled to room temperature. The reaction mixture was filtered through celite, filtrate partitioned between ethyl acetate (100 mL) and water (100 mL). The organic phase was dried (Na2SO4), filtered and evaporated to give a brown gum. The crude product was purified by flash silica chromatography, elution gradient 0 to 20% EtOAc in isohexane. Pure fractions were evaporated to dryness to afford tert-butyl 4-(5-(benzyloxy)pyridin-2-yl)piperazine-1-carboxylate (2.420 g, 68.7 %) as a yellow solid.

出典

750 AstraZeneca ELN dataset